ReviewSmall (Weinheim an der Bergstrasse, Germany)2026
SERS-Based Nano- and Microsystems Toward Biomedical Applications.
Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Light-guided SERS-active micromotor clusters for on-site detection of microorganisms.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Surface-enhanced Raman spectroscopy (SERS) has emerged as a transformative analytical technique for biomedical and bioanalytical sensing, offering molecular specificity and single-molecule sensitivity in biological environments. Recent advances in plasmonic nanomaterials, precision fabrication, and compact optical instrumentation have accelerated the development of SERS platforms with expanding potential toward biomedical applications. Despite extensive studies, clinical translation remains limited, underscoring the need for a systematic evaluation of SERS nanomaterials and device architectures under biomedically relevant conditions. This review provides a current overview of nano- and microscale SERS-based devices reported since 2020, encompassing all aspects from material design to practical applications. We highlight controlled SERS-active architectures, including patterned substrates, nanorods, microspheres, micromotors, and microneedles, as well as combinations of these microfluidic systems. We summarize key studies showing fabrication strategies, instrumentation, and analytical performance with an emphasis on platform capabilities. We present the first focused discussion on static and dynamic SERS platforms for direct, on-site molecular detection in model biological environments, and outline key challenges for biomedical translation, including reproducibility, sample handling, standardization, and integration. This review provides a practical guide for designing SERS-based nano- and microsystems toward biomedical sensing applications, while clarifying current limitations and future opportunities for translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.